Post‐remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre‐ versus post‐VIALE‐A real‐world experience from a predominantly US community setting.

Autor: Vachhani, Pankit1 (AUTHOR) pvachhani@uabmc.edu, Ma, Esprit2 (AUTHOR), Xu, Tao3 (AUTHOR), Montez, Melissa2 (AUTHOR), Worth, Sarah1 (AUTHOR), Yellow‐Duke, Archibong2 (AUTHOR), Cheng, Wei‐Han4 (AUTHOR), Werner, Michael E.4 (AUTHOR), Abbas, Jonathan5 (AUTHOR), Donnellan, William5 (AUTHOR)
Zdroj: Cancer Medicine. Sep2023, Vol. 12 Issue 17, p17914-17923. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje